Stockreport

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

Kymera Therapeutics, Inc.  (KYMR) 
PDF WATERTOWN, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral [Read more]